DAF-4 is the only type II TGF-beta/BMP receptor encoded in the C. elegans genome.
daf-4 mutants are Daf, Sma and Mab, indicating a role for this receptor kinase in continuous (non-dauer) development, normal body size and male tail development. There are two
daf-4 transcripts. During continuous growth, a 2.0 kb message is between 1.2 and 1.9-fold more abundant than the full-length 2.9 kb mRNA. In dauer larvae this ratio increases to 5-fold. However, when dauer larvae recover in fresh medium and resume growth, the relative abundance of 2.0 kb/2.9 kb mRNA declines to that of well-fed populations. This correlation suggests that alternative processing of
daf-4 may be environmentally regulated. The 2.9 kb mRNA contains an SL1-spliced 11-exon open reading frame encoding the 744-amino acid DAF-4 receptor kinase. Using RT-PCR, we cloned and sequenced a cDNA of the 2.0 kb transcript, which includes an SL1 leader, all of exons 1-5, and intron 5 sequence upstream of an alternative poly(A) addition site. The open reading frame in the 2.0 kb cDNA encodes a putative 206-amino acid polypeptide that lacks transmembrane and kinase domains, but maintains 90% of the extracellular domain. To measure the effect of overexpressing the short
daf-4 transcript on dauer formation, a
daf-4 genomic fragment containing upstream sequence through intron 5, was subcloned and microinjected with the
rol-6 marker into a weak
daf-4 mutant. In three transgenic lines, constitutive dauer formation was enhanced in Rol progeny compared to non-Rol siblings. In one line at 22.5degC, 70% of the Rol progeny formed dauer larvae, whereas only 2% of the non-Rol siblings entered diapause. These results indicate that overexpression of the short
daf-4 transgene increases dauer formation. We are currently testing whether this may be due to antagonism of DAF-4 signaling by the truncated receptor. For example, the secreted extracellular domain may bind ligand in competition with full-length receptor. Its abundance in the dauer stage may prevent dauer recovery in response to transient ligand expression.